Article Details
Retrieved on: 2017-12-19 10:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Sorrento Therapeutics logo <b>Vanguard Group</b> Inc. lifted its position in shares of Sorrento Therapeutics Inc (NASDAQ:SRNE) by 25.3% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,930,524 shares of the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here